Q92630 (DYRK2_HUMAN) Homo sapiens (Human)

Dual specificity tyrosine-phosphorylation-regulated kinase 2 UniProtKBInterProSTRINGInteractive Modelling

601 aa; Sequence (Fasta) ; (Isoform 2); 2 identical sequences: Pan troglodytes: K7BQM1, A0A6D2WG97

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The co-crystal structure of DYRK2 with YK-2-69homo-2-mer151-543
100.0YK2;
The crystal structure of human DYRK2 in complex with Curcuminhomo-2-mer146-536
100.0CUR;
Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2)monomer146-543
100.0SO4;NA;CL;
Human DYRK2 bound to Scorzodihydrostilbene Amonomer146-542
100FZ5;NA;
Human DYRK2 bound to Curcuminmonomer146-536
100.0CC9;DTD;PO4;
Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2) in compleā€¦monomer146-536
100.0IRB;CL;
Human DYRK2 in complex with Leucettine L41monomer146-536
100.03RA;EDO;PO4;
Structure of DYRK2 in complex with compound 50monomer146-535
100RK5;CL;
Structure of DYRK2 in complex with compound 58monomer146-535
100RK8;CL;
Crystal structure of DYRK2 in complex with EHT 1610 (compound 2)monomer153-538
1007A7;EDO;
The co-crystal structure of DYRK2 with YK-2-99Bmonomer151-535
100XSE;
Crystal structure of DYRK2 in complex with EHT 5372 (Compound 1)monomer153-536
1007AA;EDO;
The co-crystal structure of DYRK2 with a small molecule inhibitor 8monomer212-538
100H7X;
The co-crystal structure of DYRK2 with a small molecule inhibitor 5monomer213-538
100H7C;
The co-crystal structure of DYRK2 with a small molecule inhibitormonomer212-536
99.39CQO;
The co-crystal structure of DYRK2 with a small molecule inhibitor 7monomer215-538
100H7F;
The co-crystal structure of DYRK2 with a small molecule inhibitor 13monomer215-538
100H7O;
The co-crystal structure of DYRK2 with a small molecule inhibitor 20monomer215-538
100H7R;
The co-crystal structure of DYRK2 with a small molecule inhibitor 19monomer215-538
100H7L;
The co-crystal structure of DYRK2 with a small molecule inhibitor 17monomer215-538
100H80;
The co-crystal structure of DYRK2 with a small molecule inhibitor 6monomer215-538
100H5R;
The co-crystal structure of DYRK2 with a small molecule inhibitor 10monomer215-538
100H99;
The co-crystal structure of DYRK2 with a small molecule inhibitor 18monomer215-538
100H96;
The co-crystal structure of DYRK2 with a small molecule inhibitor 14monomer215-538
100H7U;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3k2l.1.Amonomer0.85146-543
100.00
6ekd.1.Amonomer0.54206-535
33.66

2 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23k2l.1.Amonomer0.8673-470
100.00
Isoform 26ekd.1.Amonomer0.54133-462
33.66